Recently, the mechanism that drives the immune impairment in beta-catenin overactivation has been uncovered [89], consisting of an impairment in the recruitment of CD103+ DCs, which are associated with effective anti-tumour response [90]. This evidence concerns the gene CTNNB1 and neoplasm.